Mr. Alejandro De la Parra Solomon is currently the Chief Operating Officer & Co-founder at RegenerAge Clinic / Senior Partner at WAMS, The World Academy of Medical Sciences Mexico City, Mexico Mr. Alejandro De la Parra Solomon is an entrepreneur focused on Information Technology, Education and Health. He is creative and results-driven and has 16+ years of Digital Strategy experience in architecture and implementation. Mr. De la Parra is the COO and Co-founding Partner at The Solomon Brokerage Firm. He currently leads as CEO at Mass Media Dynamics and De la Parra Mobile Solutions and is former CEO & Founder at Astrum Salud Movil and its Telemedicine service Astrum Movil. Moreover, he is COO & Co-founder at RegenerAge Clinic & RegenerAge Beauty, the Digital Strategy Director & Co-founder at Dr. Jois, BiorganicAging, What Skin Needs/WSN International Pty. Ltd. He also serves as current CMO at ReAnima Advanced Biosciences and is the Digital Media Director at Bioquark, Inc. He is also the former Latin America Region Manager and Digital Strategy adviser at CardiacSense and former CITO & Senior Partner at Cerezo Editores. Within the academic and educational fields, Mr. De la Parra is a Senior Partner, Executive Vice President: Executive Chairman of the WAMS Mobile Health Division, WAMS Chief Coordinating Officer, Member of the WAMS Executive Council (WAMS Executive Board), Member of the WAMS Education & Training Board (ETB), Member of the WAMS Editorial Board, Honorary Member of the Academy Faculty FWAMS, WAMS Digital Strategy Chairman & Fellow of the Academy. Moreover, Mr. De la Parra acts as the Chief Operating Officer and is a Co-founding Partner at The Reprogramming Medicine Association. Mr. De la Parra is also a member of the National Introducing Brokers Association and a part of the National Biofuel Board, (Alliance Program), also being the founder and former Board of Directors member of Astrum Fundación, an Advisory Board member of the Lifeboat Foundation, an Advisory Board member of the Future Worlds Center - Cyprus Neuroscience & Technology Institute (Senior TV Program), a Federated member of the International Longevity Alliance, and volunteered as Digital Strategy adviser at the Major Mouse Testing Program. He is also a member of the Web Committee at the Life Extension Advocacy Foundation / Lifespan.io and has volunteered with SENS Research Foundation for the OncoSENS Program in Digital Strategy.
Health and Social Welfare
Dr. Osorio is a innovative businessman with an distinct entrepreneurial mindset concentrated in adding value on the areas of Biotechnology (mRNA), Reprogramming & Regenerative Medicine for translational use in humans and a variety of clinical applications aimed for both the private and the public health sectors. He is the CEO of RegenerAge Clinic and RegenerAge Beauty. VP and Clinical Developer for Bioquark, Inc., CCO at Reanima Advance Biosciences Project. President at Dr. Jois an anti-aging, beauty, and cosmetic products endorsement company. VP and Chairman of the WAMS Americas Division. Earned MD degree at Westhill University. Diplomate in aesthetic medicine (UAG), Advance Fellow by the ABAARM, visiting scholar at UNC at Chapel Hill in Dermatology. Fellow in Stem Cell Medicine by the A4M and USF, Business Diplomate at ECA, enrolled Master on Health Sciences at Victoria University. Has appeared on several occasions on International media, some of his latest broadcast appearances are CNN español, TV Azteca, Excelsior Newspaper, Medicable, PharmaBoard Room, and Podcasts among others. His public appearances as a speaker at the 2018 RAADfest (San Diego), 3rd International Conference on Molecular Medicine and Diagnostics (Dubai), Global Academic Business Forum on Tissue Engineering and Regenerative Medicine (Baltimore), Second International Congress on mHealth (Shiraz), 6th International Conference on Tissue Engineering and Regenerative Medicine (S.F), 11th World Congress on Cell & Tissue Science (Tokyo), 17th International Conference on Neurology and Neuroscience (Toronto), 9th International Conference & Exhibition on Tissue Science and Regenerative Medicine (Las Vegas) among others, makes him a pioneer on the Regenerative+Reprogramming Medicine Field. His passion for football, brought as a result the Dr.Jois Foundation A.C aimed at helping those American football athletes who have sustained injury get another chance through the Regenerative & Reprogramming Medicine.
Takashiro AKITSU, Ph.D. is a full Professor for the Department of Chemistry, Faculty of Science Division II at Tokyo University of Science. He completed his undergraduate school training (chemistry) from Osaka University, Japan and his graduate school training (physical & inorganic chemistry, especially coordination, crystal, and bioinorganic chemistry) from Osaka University (Ph.D. 2000). After Keio University and Stanford University, He moved to the current affiliation since 2008. Dr. Akitsu has published up to about 180 articles in peer-reviewed journals and has had posters presented at international level. He has been a peer reviewer of many journals and acted as an organizing committee of several international conferences.
crystal and bio inorganic chemistry
Linnikov Oleg Dmitrievich, Head of Research laboratory, Institute of Solid State Chemistry, Ural Branch of the Russian Academy of Sciences (RAS), Ekaterinburg, Russia. Education: Ural. Poly. Inst., Ekaterinburg, Russia, diploma (hon.), Institute of Solid State Chemistry, Ural Branch of the Russian Academy of Sciences (RAS), Ekaterinburg, PhD, 1996; Doctor of Sciences (Physical Chemistry), 2012 (the Russian Doctor of Science degree is the highest research degree in this country).
Alexei Finkelstein: Born in 1947 (Kharkov, Ukraine, USSR). Alma Mater: Moscow PhysTech. (MSc: 1970). Ph.D. (Biophysics, Moscow PhysTech., 1976); LMB (Cambridge) alumnus, 1988;D.Sc. (Biophysics, Moscow Univ., 1991). Author of >250 scientific papers and books "Protein Physics", (five Russian, two English and two Chinese editions), and "Physics of Protein Molecules" (in Russian). Citation index by Google Scholar: about 8500, Hirsch index: 43. Since 1970, member, and since 1999, Head of Protein Physics Laboratory at the Institute of Protein Research, RAS. Since 1998, Full professor of the Moscow University. Awards from FIRCA, INTAS, CASP, HHMI (3 times), RFBR, RSF, Moscow Grant, etc. State Prize of Russia in Science (1999); elected to the Russian Academy of Sciences (2008).
Rashid Mahmood has Master Degree in Analytical Chemistry and MS in Total Quality Management. He has 15 years of experience of Pharmaceutical Quality Operations and has attended many international conferences as a keynote speaker. He has presented various talks in USA & China on Cleaning Validation, cGMP Guidelines, Quality Risk Management, Role of Mass Spectrometry in Pharmaceuticals and on new Drug Delivery Systems. Currently he is working as a Senior Executive Manager Quality Operations for Surge Lab.(Manufacturer of Microencapsulated APIs, Liquid & Dry Powder Parentrals) which is the best export oriented organization of Pakistan.
Dr. Alain L Fymat is a medical-physical scientist and an educator. He is the current President/CEO and Professor at the International Institute of Medicine and Science with a previous appointment as Executive Vice President, Chief Operating Officer and Professor at the Weil Institute of Critical Care Medicine. He was educated at the University of Paris-Sorbonne and the University of California at Los Angeles. He was formerly Professor of Radiology, Radiological Sciences, Radiation Medicine (Oncology), Critical Care Medicine, and Physics at several U.S. and European Universities. Previously, he was Deputy Director (Western Region) of the U.S. Department of Veterans Affairs, Veterans Health Administration (Office of Research Oversight), and Director of the Magnetic Resonance Imaging Center and for a time Acting Chair of Radiology at its Loma Linda, California Medical Center. He has extensively published (~ 425 publications including patents, books & monographs, book chapters, refereed articles). As invited/keynote speaker and member of organizing committees of international congresses and symposia, he has lectured extensively across the USA, Canada, Europe, Africa and Asia. He has been the recipient of numerous research grants from government, academia and private industry, and has consulted extensively with these entities. He is a Board member of several institutions and Health Advisor of the American Heart & Stroke Association (Coachella Valley Division, California). He is Editor-in-Chief, Honorable Editor or Editor of 35 medical-scientific Journals. He published more than 37 articles in different journals.
Interface between science and medicine, particularly nanomedicine, nanobiotechnology, cancer/oncology, molecular/personal/precision medicine, human genetics/ epigenetics/ ecogenetics, neurodegenerative diseases, and pharmacogenomics, nanotechnology and cancer, nanochemotherapy, nanoneurology, natural and synthetic immunotherapy, drug delivery across the brain protective barriers, and neurodegenerative disorders (epilepsy, Parkinson's and Alzheimer's diseases).
Vitaly Ovchinnikov has completed his PhD at the age of 26 years from University of Kazan (Russia). He is professor at Kazan national research technical university (KNITU-KAI). He has published more than 100 papers in reputed journals.
Microbial Culture Isolation & Preservation ? Microbial Technology & Fermentation Production of enzymes such as cellulases, xylanases, lipases, pectinases, hydantoinases, Citric acid and lactic acid fermentations. Biomass conversion to value added products such as ethanol and lactic acid. ? Microbial Strain Improvement Cellulase, ethanol and lactic acid producing strains were improved using traditional approaches such as mutations, protoplast fusion in bacteria, yeast and fungi. ? Bio-transformations ? Chemoenzymatic process for chiral amino acids such as phenyl glycine, ? Process for prostaglandin intermediate using isolated yeast strain. Licensed to Hygeia Laboratory. ? Transesterifications using lipases. Achievements ? Fellow of Biotech Research Society of India (BRSI) ? Member of American Chemical Society ? Published over 80 papers in reputed international journals. ? Indian Patents: 4 ? US Patents: 6
Dr. Carolle-Laure KPOUMIE has worked as pediatric assistant physician in pediatric’s department of faculty of medicine in Cameroon, as clinical researcher methodology, scientific writing, public health, oncology, internal medicine and continued her career in pharmaceutical industries in France. She participates in many congress with studies made in hospitals on relevant cases in the framework Studies and clinical research. She became head of department, director, head of district where she continued her research, writing of treatment protocols in different departments for common pathologies encountered in her context, managing Epidemic crisis such as cholera, meningitis, avian influenza, yellow fever and organizes campaigns on infectious diseases ,HIV, cardiovascular diseases, family planning, research on severe malaria, malnutrition in Children and participates in studies on neonatal mortality in underdeveloped countries. She work on ADR in hospital following drug administration, pharmacovigilance, vaccinovigilance, biovigilance, materiovigilance, pharmacovigilance in underdeveloped countries, articles, medical information and therapeutic safety, clinical trials, Post-marketing, and other’s studies.
Dr. Ian James Martins is an Editor/Reviewer for Open Acess Pub/MDPI journals and various other international journals. Advisory Board Member for Photon Journal. Fellow of International Agency for Standards and Ratings (IASR). Conferred with the RICHARD KUHN RESEARCH AWARD-2015 ENDOCRINOLOGY AND METABOLISM. Chief Editor for International Journal of Diabetes Research (2014-2018), Research and Reviews: Neuroscience (2016-2018) and Journal of Diabetes and Clinical Studies (2017-2018). BIT Member (BIT Congress. Inc) with an h-index of 65, (ResearchGate STATs (28), Scopus Author ID: 7103152779/Mendeley STATS (21), UWA Research Repository (16). Scientist for The Science Advisory Board (USA) and an Academic with Academia.edu. The citations past 27 years have accumulated to >4741. Ian James Martins - Semantic Scholar https://www.semanticscholar.org/author/Ian-James-Martins/5258067. Semantic Scholar profile for Ian James Martins, with fewer than 50 highly influential citations RESEARCHGATE ANALYSIS: Ian J Martins | Ph D | Centre of Excellence for Alzheimer's Disease ...https://www.researchgate.net/profile/Ian_Martins2 under Ian James Martins’ name places publication RG score (> 96%) of international SCIENTISTS. ORCID CONNECTING RESEARCHER: Editorial Team www.macrothink.org/journal/index.php/jfs/about/editorialTeamBio/13511 Editorial Team. Ian James Martins. Ian James Martins Mail • http://orcid.org/0000-0002-2390-1501. Edith Cowan University, Australia. Prestigious Recognition of Lifetime Membership by the International Agency for Standards and Ratings as Fellow for Diabetes, Medical Science (Nutrition). Winner (World Academic Championship -2017) in Diabetes and Medical Science (Nutrition). Certificates from various international conferences have been received in relation to anti-aging, health, and disease. Keynote addresses at, Biomedicine 2018 (Osaka, Japan), Global Experts Meeting on Diabetes, Hypertension, Metabolic Syndrome 2018 (Melbourne, Australia), Immunology World 2018 (Amsterdam, Netherlands), Laboratory Medicine 2018 (Berlin, Germany), Innovate Pharma 2017 (Sydney, Australia), Innovate Neurology 2017(Sydney, Australia) World Diabetes and Endocrinology Summit-2017 (Dubai), Pharmacology and Ethnopharmacology 2016 (Chicago, USA) and AGHC 2016 (1st Plenary Speaker, Kaohsiung, Taiwan). Chair/Co-chair Sessions on Laboratory management, Cytogenetics, Clinical Microbiology, Diagnostic Laboratory Medicine etc, 13th International Conference on Laboratory Medicine and Pathology, Berlin, Germany, June 25-26, 2018, Chairing Sessions on Vaccinology, Immunopathology, Immunotherapy, Immune Proteomics, Cancer and Tumour Oncology, 7th World Congress on Immunology, Amsterdam, Netherlands, April 19-20, 2018, Chair, Pipeline 1: Biotherapeutics for Diseases, Bit's 2nd International Congress of Biotherapy-2018 (Programme Committee Member), Chair, Innovate Conferences 2017, Chair/Co-Chair at congress World Gene Convention-2016 (Shanghai, China, Pharmacology and Ethnopharmacology 2016 (Chicago, USA), Annual World Congress of Diabetes-2014 (Haikou, China), World Gene Convention-2014 (Haikou, China). Research Activity Statistics provided by Publons with a comparison to other researchers indicates Ian James Martins to be a VERIFIED REVIEWER. Ian James Martins is now in the 98th percentile as assessed for Publons users by merit. Dr. Ian Martins is a reviewer for approx. 90 journals over the past 5 years. Organizing Committee and Advisory Board Member [h-index=65] (approx. 30 conferences): Organizing Committee Member, 3rd International conference on Neurology and Brain Disorders Milan Italy.during 25-26,2019, Organizing Committee Member Future Trends in Neurosciences 2019 Brussels, Belgium, Organizing Committee Member, 14th International Conference on Laboratory Medicine & Pathology in London, UK, Organizing Committee Member, 7th International Conference on Neurology and Neuromuscular Diseases that is slated on October 22-23, 2018 at Madrid, Spain, Organizing Committee Member 3rd Edition of International Conference on Neurology and Brain Disorders (INBC 2019), Organizing Committee Member, Euro Diabetes 2019 Congress, Edinburgh, Scotland Advisory Committee Member, 2nd International Conference on Medicinal Chemistry & Drug Design” (Medicinal Chemistry-2019) during August 19-20, 2019 in Barcelona, Spain, Advisory Board Member, Global Experts Meeting on Frontiers in Nanomedicine and Drug Delivery” (Nanodelivery 2019) scheduled during March 18-20, 2019 at London, UK, Organizing Committee Member, Conference on Food Science and Nutrition, 25 -26 February 2019,Rome, Italy, International Conference on PharmScience Research & Development” scheduled in Paris, France during March 04-06, 2019, Advisory Board Member World conference on Microbiology and Immunology2019, May 13-15th , 2019 Cape town, South Africa, Advisory Board Member 5th Neurological Disorders summit (NDS-2019) in Los Angeles, Organizing Committee Member, International Conference on Traditional Medicine and Ethno botany held at the Valencia, Spain on April 10-12, 2019, Organizing Committee Member, International Conference on Stem Cells, Biobanking and Tissue Preservation scheduled during 12-13th December 2018 at Abu Dhabi, UAE, Organizing Committee Member, International Conference on Heart & Diabetes" (ICHD 2019) along with external scientific association with the researches, academicians, and Pharmaceutical market leaders around the globe, scheduled on August 19-20, 2019 at Osaka, Japan, Organizing Committee Member, 2nd International Pharmaceutical Conference and Expo to take place on June 05-07, 2019 in Baltimore, USA, Advisory board member, International Summit on Vaccines and Immunology” (AEM VACCINES-2018) which is scheduled to be held on the 05th - 06th December 2018, etc.